BERTI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 8.330
AS - Asia 6.580
EU - Europa 5.878
SA - Sud America 425
AF - Africa 111
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.380
Nazione #
US - Stati Uniti d'America 8.189
HK - Hong Kong 2.765
RU - Federazione Russa 1.961
IT - Italia 1.254
SG - Singapore 1.239
CN - Cina 1.159
PL - Polonia 1.055
KR - Corea 375
IE - Irlanda 370
VN - Vietnam 346
BR - Brasile 333
SE - Svezia 333
DE - Germania 225
FI - Finlandia 168
FR - Francia 160
IN - India 159
BD - Bangladesh 144
GB - Regno Unito 117
JO - Giordania 97
CA - Canada 89
NL - Olanda 62
ID - Indonesia 60
JP - Giappone 59
AU - Australia 52
TR - Turchia 42
AR - Argentina 36
CH - Svizzera 34
ES - Italia 33
UA - Ucraina 33
IQ - Iraq 32
MX - Messico 30
ZA - Sudafrica 29
TN - Tunisia 18
AT - Austria 17
CI - Costa d'Avorio 16
CO - Colombia 16
NG - Nigeria 15
PK - Pakistan 14
EC - Ecuador 13
BE - Belgio 11
PH - Filippine 10
SA - Arabia Saudita 10
CZ - Repubblica Ceca 9
VE - Venezuela 9
BJ - Benin 8
UZ - Uzbekistan 8
CL - Cile 7
MA - Marocco 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
IL - Israele 6
KE - Kenya 6
LT - Lituania 6
GR - Grecia 5
IR - Iran 5
JM - Giamaica 5
TW - Taiwan 5
DK - Danimarca 4
EG - Egitto 4
PS - Palestinian Territory 4
RO - Romania 4
UY - Uruguay 4
DZ - Algeria 3
KZ - Kazakistan 3
MM - Myanmar 3
NI - Nicaragua 3
PE - Perù 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AM - Armenia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
PA - Panama 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
Totale 21.370
Città #
Hong Kong 2.696
Santa Clara 1.515
Ashburn 1.412
Warsaw 1.042
Singapore 934
Fairfield 640
San Jose 380
Seoul 369
Chandler 368
Dublin 367
Woodbridge 278
Hefei 266
Seattle 240
Houston 223
Cambridge 214
Beijing 204
Wilmington 184
Milan 162
Florence 154
Dallas 146
Altamura 134
Lawrence 129
Los Angeles 119
Ho Chi Minh City 117
Ann Arbor 113
Munich 102
Council Bluffs 101
Buffalo 98
New York 93
Moscow 91
Lauterbourg 86
Princeton 82
The Dalles 73
Rome 70
Hanoi 69
Helsinki 68
Mumbai 67
Boston 64
Shanghai 51
Kent 49
Jakarta 47
Melbourne 47
Tokyo 47
São Paulo 46
Boardman 43
San Diego 42
Turku 40
Orem 39
Dearborn 35
Frankfurt am Main 34
Naples 34
Amsterdam 31
Bologna 30
Medford 30
Bremen 29
Paris 29
Bern 28
Guangzhou 28
Lappeenranta 28
Pune 28
Jacksonville 26
London 25
Toronto 24
Johannesburg 22
West Jordan 22
Clifton 20
Turin 20
Denver 18
Montreal 18
Phoenix 18
Redondo Beach 17
Stockholm 17
Abidjan 16
Chennai 16
Chicago 16
Nashville 16
San Francisco 16
Atlanta 15
Brooklyn 15
Figino 15
Hillsboro 15
Falls Church 14
Norwalk 14
Sesto Fiorentino 14
Abuja 13
Bengaluru 13
Haiphong 13
Dong Ket 12
Miano 12
Yubileyny 12
Brussels 11
Manchester 11
Mexico City 11
Prato 11
Tianjin 11
Venice 11
Wroclaw 11
Ankara 10
Barcelona 10
Brasília 10
Totale 14.896
Nome #
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 2.299
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 401
Bile leak after elective laparoscopic cholecystectomy: Role of MR imaging 345
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 336
Relationship between infarct size and severity measured by gated SPECT and long-term left ventricular remodelling after acute myocardial infarction. 335
Fetal striatal grafting slows motor and cognitive decline of Huntington's disease 303
FDG PET and the genetics of dementia 297
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. 287
The use of Deauville 5-point score could reduce the risk of false-positive fluorodeoxyglucose-positron emission tomography in the posttherapy evaluation of patients with primary bone lymphomas 268
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 257
Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana 251
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 251
Neuroimaging studies in subjects at genetic risk of developing Alzheimer's disease: the role of neuroimaging to reveal the endophenotype 247
Amyloid Angiopathy related inflammation and paroxysmal events refractory to anti-seizure therapy: amyloid spells or seizures? 238
Typical lung carcinoids: review of classification, radiological signs and nuclear imaging findings 224
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 220
Metastatic intracranial solitary fibrous tumors/hemangiopericytomas: description of two cases with radically different behaviors and review of the literature 220
Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. 217
Clinical correlation of the binding potential with (123)I-FP-CIT in de novo idiopathic Parkinson's disease patients. 215
Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease 215
Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery 214
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 214
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 198
Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques 195
CT assessment of tumor heterogeneity and the potential for the prediction of human papillomavirus status in oropharyngeal squamous cell carcinoma 194
Diagnostic imaging of typical lung carcinoids: relationship between MDCT, 111In-Octreoscan and 18F-FDG-PET imaging features with Ki-67 index 194
Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT 193
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 192
Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: Numerical and patient data evaluation 192
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 192
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. 191
Biomarkers study in atypical dementia: proof of a diagnostic work-up 190
Laparoscopic splenectomy as quaternary cytoreduction for isolated parenchymal splenic recurrence of epitelial tubo-ovarian cancer: Report of a case and literature review 189
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. 186
PET/CT in diagnosis of dementia. 185
99mTc-EDDA/HYNIC-TOC is a new opportunity in Neuroendocrine Tumors of the Lung (and in other malignant and benign pulmonary diseases) 185
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 184
Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study 184
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 184
Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps 184
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 183
Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease. 183
Primary Progressive Aphasia: Natural History in an Italian Cohort 182
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 182
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 181
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 181
Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters 179
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 178
Characterization of functionally significant coronary artery disease by a coronary computed tomography angiography-based index: a comparison with positron emission tomography. 178
Amyloid PET in the diagnostic workup of neurodegenerative disease 178
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 177
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 174
Metabolic Imaging in B-Cell Lymphomas during CAR-T Cell Therapy 172
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma 172
Nutrient patterns and brain biomarkers of Alzheimer’s disease in cognitively normal individuals 172
Back to the future: the absolute quantification of cerebral metabolic rate of glucose 171
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation 171
Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging 171
PET/CT in diagnosis of movement disorders. 170
Detection of infarct size safety threshold for left ventricular ejection fraction impairment in acute myocardial infarction successfully treated with primary percutaneous coronary intervention. 170
Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report 165
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 165
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 163
Electronic processing of digital panoramic radiography for the detection of apical periodontitis 163
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 162
Structural brain changes in normal individuals with a maternal history of Alzheimer's 161
Evaluation of age and sex-related metabolic changes in healthy subjects: An italian brain 18f-fdg pet study 161
Comparing two picture naming tasks in primary progressive aphasia: Insights from behavioural and neural results 159
Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement 159
Evaluation of early dementia (Mild cognitive impairment) 159
Alzheimer's disease: genetic basis and amyloid imaging as endophenotype 159
A tale of two tracers: Glucose metabolism and amyloid positron emission tomography imaging in Alzheimer's disease 159
ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications 155
A case of hemichorea/hemiballismus in a patient with Alzheimer’s disease and history of Sydenham’s chorea: the return of an old acquaintance? 155
Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors 155
Brain metabolic connectivity reconfiguration in the semantic variant of primary progressive aphasia 155
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 155
Anatomical remodelling of human striatum after neural transplantation in Huntington's disease 155
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults 154
Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease 152
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 151
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 151
Diagnostic and therapeutic challenges in mast cell sarcoma 150
Sex differences in Alzheimer risk 149
Human Striatum Remodelling after Neurotransplantation in Huntington's Disease. 148
Molecular imaging and parkinson's disease 148
Comprehensive qualitative characterization of linguistic performance profiles in primary progressive aphasia: a multivariate study with FDG-PET 144
Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study 142
Sokoloff and Patlak methods for CMRGlu quantification with aortic image-derived input function: A feasibility study 141
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition 139
The role of molecular imaging in the frame of the revised dementia with Lewy body criteria 137
Applications of PET and SPECT in Patients with Autism Spectrum Disorder 136
Early detection of Alzheimer's disease with PET imaging. 136
Reliability of myocardial perfusion gated SPECT for the reproducible evaluation of resting left ventricular functional parameters in long-term follow-up. 130
Neural correlates of naming errors across different neurodegenerative diseases: A FDG-PET study 130
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 129
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. 127
Brain : Normal Variations and Benign Findings in Fluorodeoxyglucose-PET/Computed Tomography Imaging 125
Segmental quantitative myocardial perfusion with PET for the detection of significant coronary artery disease in patients with stable angina 120
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities 115
Totale 20.710
Categoria #
all - tutte 57.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022678 33 44 86 50 16 28 22 52 27 38 115 167
2022/20231.779 146 371 100 137 110 301 235 79 200 15 38 47
2023/20241.024 27 82 89 31 56 115 38 369 22 74 85 36
2024/20255.243 157 525 298 935 1.304 637 97 433 176 129 235 317
2025/20269.250 723 2.962 667 592 855 269 843 344 420 524 291 760
2026/2027114 114 0 0 0 0 0 0 0 0 0 0 0
Totale 21.549